Publicaciones en las que colabora con José Ignacio Riezu Boj (59)

2024

  1. Inflammatory markers as diagnostic and precision nutrition tools for metabolic dysfunction-associated steatotic liver disease: Results from the Fatty Liver in Obesity trial

    Clinical Nutrition, Vol. 43, Núm. 7, pp. 1770-1781

2023

  1. A Predictive Tool Based on DNA Methylation Data for Personalized Weight Loss through Different Dietary Strategies: A Pilot Study

    Nutrients, Vol. 15, Núm. 24

  2. Crosstalk between Gut Microbiota and Epigenetic Markers in Obesity Development: Relationship between Ruminococcus, BMI, and MACROD2/SEL1L2 Methylation

    Nutrients, Vol. 15, Núm. 7

2022

  1. A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers

    Panminerva medica, Vol. 64, Núm. 4, pp. 485-496

  2. A weight-loss model based on baseline microbiota and genetic scores for selection of dietary treatments in overweight and obese population

    Clinical Nutrition, Vol. 41, Núm. 8, pp. 1712-1723

  3. Differentially methylated regions (DMRs) in PON3 gene between responders and non-responders to a weight loss dietary intervention: a new tool for precision management of obesity

    Epigenetics, Vol. 17, Núm. 1, pp. 81-92

  4. Possible metabolic interplay between quality of life and fecal microbiota in a presenior population–Preliminary results

    Nutrition, Vol. 103-104

2021

  1. A predictive regression model of the obesity-related inflammatory status based on gut microbiota composition

    International Journal of Obesity, Vol. 45, Núm. 10, pp. 2261-2268

  2. Diet- and sex-related changes of gut microbiota composition and functional profiles after 4 months of weight loss intervention

    European Journal of Nutrition, Vol. 60, Núm. 6, pp. 3279-3301

  3. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study

    European Journal of Nutrition, Vol. 60, Núm. 6, pp. 3043-3057

  4. Epigenetic signatures underlying inflammation: an interplay of nutrition, physical activity, metabolic diseases, and environmental factors for personalized nutrition

    Inflammation Research, Vol. 70, Núm. 1, pp. 29-49

  5. Gut microbiota bacterial species associated with mediterranean diet-related food groups in a northern spanish population

    Nutrients, Vol. 13, Núm. 2, pp. 1-17

  6. Gut microbiota differences according to ultra-processed food consumption in a spanish population

    Nutrients, Vol. 13, Núm. 8

  7. Potential Mechanisms Linking Food-Derived MicroRNAs, Gut Microbiota and Intestinal Barrier Functions in the Context of Nutrition and Human Health

    Frontiers in Nutrition, Vol. 8

  8. Test metagenómicos y de disbiosis: presente y futuro

    Revista española de nutrición humana y dietética, Vol. 25, Núm. 3, pp. 20-21

  9. The hypertriglyceridemic-waist phenotype as a valuable and integrative mirror of metabolic syndrome traits

    Scientific reports, Vol. 11, Núm. 1, pp. 21859

  10. Three different genetic risk scores based on fatty liver index, magnetic resonance imaging and lipidomic for a nutrigenetic personalized management of nafld: The fatty liver in obesity study

    Diagnostics, Vol. 11, Núm. 6

2020

  1. Association of the SH2B1 RS7359397 gene polymorphism with steatosis severity in subjects with obesity and non-alcoholic fatty liver disease

    Nutrients, Vol. 12, Núm. 5

  2. Circulating adiposity-related microRNAs as predictors of the response to a low-fat diet in subjects with obesity

    Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 5, pp. 2956-2967

  3. Comprehensive analysis reveals novel interactions between circulating micrornas and gut microbiota composition in human obesity

    International Journal of Molecular Sciences, Vol. 21, Núm. 24, pp. 1-17